Funds and prices
Overview
Very actively managed equity fund. The portfolio is primarily focused on securities from large companies though strategically supplemented by securities from small and medium-sized companies.
The fund manager is given great flexibility to take focused views on the most attractive stocks and exploit the best opportunities, unconstrained by the reference index.
The fund offers investors a broader diversification compared to the index including lower maximum single stock weights (max. 10%) and a more balanced sector allocation.
The portfolio manager is not tied to the benchmark in terms of investment selection or weight.
Benefits
The fund draws on the knowledge of proven investment specialists based in Zurich (Switzerland).
Due to the significant deviation from the reference index, the fund offers the potential to outperform the reference index.
ÃÛ¶¹ÊÓƵ's proprietary fundamental valuation approach allows consistent selection of attractive Swiss companies.
Investors benefit from a global investment platform of ÃÛ¶¹ÊÓƵ Asset Management.
Risks
Features
Product category |
ÃÛ¶¹ÊÓƵ Equity Funds
ÃÛ¶¹ÊÓƵ Opportunity Equity Funds |
Product domicile |
Luxembourg
|
Portfolio management |
ÃÛ¶¹ÊÓƵ Asset Management Switzerland AG, Zurich
|
Fund management |
ÃÛ¶¹ÊÓƵ Fund Management (Luxembourg) S.A., Luxembourg
|
Custodian bank |
ÃÛ¶¹ÊÓƵ Europe SE, Luxembourg Branch
|
Representative for products established under foreign law |
ÃÛ¶¹ÊÓƵ AG, Stockholm
|
Day of inception |
November 16, 2010
|
Currency of account |
CHF
|
Close of financial year |
May 31
|
Issue / redemption |
daily
|
Distribution |
Reinvestment
|
Maturity |
Open end
|
Management fee |
1.20% p.a.
|
Total expense ratio (TER) |
1.57% p.a.
|
Swing pricing |
yes
|
Minimum investment |
n.a.
|
Reference Index / Benchmark |
SPI® (TR)
|
ISIN |
LU0546265769
|
Bloomberg Ticker |
ÃÛ¶¹ÊÓƵSOPC LX
|
Telekurs Id |
n.a.
|
Performance and Prices
Percentage growth
as of April 3, 2024CHF(%) | EUR(%) | SEK(%) | |
YTD | |||
1M | |||
3M | |||
6M | |||
1Y | 1.14 | 2.53 | 4.54 |
2Y | |||
3Y | -0.23 | 12.90 | 26.85 |
5Y | 20.86 | 38.00 | 52.76 |
ø p.a.5Y | 3.86 | 6.65 | 8.84 |
Current data
Net asset value | 03.04.2024 | CHF 216.59 |
High - last 12 months | 08.05.2023 | CHF 222.52 |
Low - last 12 months | 27.10.2023 | CHF 192.86 |
Assets of the unit class in mn | 03.04.2024 | CHF 37.63 |
Total product assets in mn | 03.04.2024 | CHF 51.77 |
Date
|
2 years
|
5 years
|
|
Total risk reference index / benchmark | 29.02.2024 | 12.60% | 12.59% |
Sharpe Ratio | 29.02.2024 | -0.29 | 0.29 |
Risk Free Rate | 31.03.2024 | 0.87% | -0.06% |
Structures
By the 10 largest equity positions (in %, as of February 29, 2024)
|
|
Roche Holding AG | 9.62 |
Novartis AG | 9.41 |
Nestle SA | 9.12 |
Zurich Insurance Group AG | 7.69 |
Swiss Re AG | 5.11 |
ABB Ltd | 5.10 |
ÃÛ¶¹ÊÓƵ Group AG | 4.83 |
Lonza Group AG | 4.09 |
Swiss Life Holding AG | 3.74 |
Cie Financiere Richemont SA | 3.15 |
Fees
Distributions
Authorisations
Literature
Document type
|
Document Language
|
|
Prospectus |
|
|
Key Information Document |
|
|
Past performance |
|
|
Previous performance scenario |
|
|
Statutes / Management regulations |
|
|
ESG Disclosure |
|
|
Document type
|
Document Language
|
Annual report |
|
Semi-annual report |
|